Can an ectoin inhaler tame mild asthma?
NCT ID NCT01478152
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested an inhaled solution of Ectoin, a natural substance, in 18 adults with mild asthma. The goal was to find a safe dose and see if it reduces airway sensitivity. Participants inhaled different doses over short periods, and results were compared to a placebo. The study was small and short, so more research is needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ectoin inhalation solution
- What this could lead to
- If it works, this could point toward a new inhaled treatment to help control mild asthma symptoms.
- What could go wrong
- This was a very small, early-phase study with only 18 people, so results may not apply broadly. It also tested each dose for just 5-7 days, so long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inamed Research GmbH & Co KG
Gauting, Bavaria, 82131, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking severe asthma over time unlock better treatments?
- Can pressurized breathing boost mucus clearance in lung disease?
- Can a simple breathing test unlock the secrets of chronic cough?
- Can a Breath-Activated inhaler match the standard for asthma control?
- Can a School-Home program tame childhood asthma?
- Could everyday supplements shield your lungs?